GoodRx (GDRX) vs Heartflow (HTFL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Heartflow (HTFL) has outperformed GoodRx (GDRX) over the past year, gaining 33.2% versus a loss of 23.5%. Heartflow is the larger company by market cap ($4.33 billion vs $1.17 billion), about 3.7 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GDRX | HTFL |
|---|---|---|
| Share price | $3.43 | $49.74 |
| Market cap | $1.17B | $4.33B |
| 1-day change | +2.08% | +4.43% |
| YTD return | +23.99% | +63.40% |
| 1-year return | -23.46% | +33.19% |
| 5-year return | -92.08% | — |
| P/E ratio (TTM) | 68.60 | — |
| Forward P/E | 9.67 | — |
| EPS (TTM) | $0.05 | $-0.24 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $176.03M |
| Revenue growth (YoY) | — | +39.92% |
| Net income (latest FY) | — | $-116.79M |
| Gross margin | — | 76.80% |
| Operating margin | — | -36.39% |
| Net margin | — | -66.35% |
| 52-week high | $4.72 | $54.32 |
| 52-week low | $1.77 | $20.13 |
| Distance from 52-week high | -27.33% | -8.43% |
| Analyst consensus | hold | none |
| Avg. price target upside | +15.16% | -7.52% |
| Average volume | 1.27M | 1.81M |
| Shares outstanding | 107.18M | 86.95M |
| Employees | 697 | 843 |
| Sector | Technology | Health Care |
| Industry | EDP Services | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Heartflow is about 3.7 times larger than GoodRx by market value ($4.33B vs $1.17B).
- HTFL has outperformed GDRX by 56.7 percentage points over the past year.
- The two companies sit in different sectors: GoodRx in Technology and Heartflow in Health Care.
About GoodRx
GDRX stock →GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices.
Technology · EDP Services · 697 employees
About Heartflow
HTFL stock →HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries.
Health Care · Medical/Dental Instruments · 843 employees
GDRX vs HTFL FAQ
Which is bigger, GoodRx or Heartflow?
Heartflow (HTFL) is larger, with a market capitalization of $4.33B compared with $1.17B for GoodRx (GDRX).
Which stock has performed better over the past year, GDRX or HTFL?
HTFL returned +33.19% over the past 12 months, compared with -23.46% for GDRX (price return, excluding dividends). Past performance does not predict future results.
Are GoodRx and Heartflow in the same industry?
No. GoodRx is in the Technology sector, while Heartflow is in Health Care.